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*Klebsiella quasipneumoniae*, formerly *Klebsiella pneumoniae* phylogroup KpII, was recently taxonomically reclassified as a new sister species of *K. pneumoniae* with two subspecies, *K. quasipneumoniae* subsp. *quasipneumoniae* and *K. quasipneumoniae* subsp. *similipneumoniae* ([@B1]). *K. quasipneumoniae*, like *K. pneumoniae*, can cause human infections but is considered less pathogenic and more often associated with carriage than clinical disease ([@B1], [@B2]). However, severe human infections with *K. quasipneumoniae* have been reported ([@B3], [@B4]). Here, we report the draft genome sequence of a multidrug-resistant *K. quasipneumoniae* subsp. *similipneumoniae* strain, isolated from the gastrointestinal tract of a hospitalized patient.

*K. quasipneumoniae* subsp. *similipneumoniae* strain KP_Z4175 was isolated from a screening rectal culture obtained for infection control purposes from a 53-year-old patient. The patient had a remote history of simultaneous pancreas-kidney transplant, was currently receiving immunosuppressive treatment, and had recently undergone colectomy for an obstructing cecal lymphoma. He was admitted to a tertiary care hospital with increased ostomy output that resolved with medical management. There were no signs of active infection throughout the hospitalization. The isolate was identified as having extended-spectrum β-lactamase activity by CLSI double-disk diffusion Kirby-Bauer testing ([@B5]).

KP_Z4175 DNA was sequenced on the MiSeq platform (Illumina Inc., San Diego, CA, USA) generating 2 × 301-bp paired-end reads. A total of 15,256,306 reads were produced comprising 1,540,886,906 bases after adapter sequence trimming. *De novo* assembly was performed using SPAdes version 3.6.2 ([@B6], [@B7]) to generate 97 contigs at least 200 bp in length for a total sequence of 5,598,139 bp. The assembly *N*~50~ was 332,350 bp, and the average GC content was 57.6%. Annotation was performed by the NCBI Prokaryotic Genome Annotation Pipeline and contained 5,398 coding sequences. Speciation was confirmed by *fusA*, *gapA*, *gyrA*, *leuS*, and *rpoB* analysis ([@B1]) and predicted DNA-DNA hybridization of 93.7% against *K. quasipneumoniae* subsp. *similipneumoniae* strain 07A044 (accession no. CBZR00000000) using the GGDC 2.1 software ([@B8]).

To examine the antibiotic resistance profile of *K. quasipneumoniae* subsp. *similipneumoniae* strain KP_Z4175, antibiotic resistance genes were identified using ResFinder version 2.1 ([@B9]). In addition to *bla*~OKP-B-1~, a β-lactamase characteristic of *K. quasipneumoniae* ([@B10]), β-lactamase *bla*~OXA-10~ and the extended-spectrum β-lactamase *bla*~SHV-12~ were identified. Also identified were three aminoglycoside resistance genes (*aadA1*, *aacA4*, and *aac(6′)-IIc*), two fluoroquinolone resistance genes (*aac(6′)Ib-cr* and *QnrB4*), one macrolide-lincosamide-streptogramin B resistance gene (*ere(A)*), two phenicol resistance genes (*cmlA1* and *floR*), one rifampin resistance gene (*ARR-2*), two sulfonamide resistance genes (*sul1* and *sul2*), one tetracycline resistance gene (*tet(D)*), and one trimethoprim resistance gene (*dfrA14*). All identified resistance genes had nucleotide identities of 98.35 to 100% over 85 to 100% of the reference gene lengths. Broth microdilution testing using CLSI breakpoints for *Enterobacteriaceae* indicated that KP_Z4175 is resistant to gentamicin (MIC \>64), tobramycin (=32), cefazolin (\>64), ceftriaxone (\>64), aztreonam (\>64), and trimethoprim-sulfamethoxazole (\>64). The isolate had intermediate resistance to ampicillin-sulbactam (=16) and pipericillin/tazobactam (=32), and was sensitive to ertapenem (≤0.03), imipenem (=1), meropenem (≤0.03), amikacin (=0.5), cefepime (=8), and ciprofloxacin (=1).
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This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under the accession number [LVCD00000000](http://www.ncbi.nlm.nih.gov/nuccore/LVCD00000000). The version described in this paper is version LVCD01000000.
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